| Gene symbol | TNFRSF17 | Synonyms | BCM, BCMA, CD269, TNFRSF13A | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p13.13 | dbXrefs | |
| Description | TNF receptor superfamily member 17 | ||||
| GTO ID | GTC0807 |
| Trial ID | ChiCTR1900024088 |
| Disease | Plasma Cell Neoplasm |
| Altered gene | BCMA |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | BCMA CAR-T cells |
| Phase | Early_Phase1 |
| Recruitment status | Not Recruiting |
| Title | A single-center, open, single-arm clinical study for evaluating the safety and efficacy of re-infusion of BCMA CAR-T in the treatment of relapsed/refractory BCMA+ plasma cell tumors |
| Year | 2019 |
| Country | China |
| Company sponsor | Tongji Hospital of Tongji Medical College, Huazhong University of Science |
| Cohort 1 | |||||||
|
|||||||